1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,828 | 0,970 | 13:05 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| DIAGNOSTIC MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 20.07. | DMS GROUP: Q2 2026 REVENUE: EUR 12.2 MILLION | 605 | Actusnews Wire | A penalizing market environment in Radiology in H1 2026, temporarily impacted by the global context and by the postponement of the last deliveries of equipment under the contract in Ukraine
Strong... ► Artikel lesen | |
| 02.07. | DMS GROUP: HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON JUNE 30, 2026 | 462 | Actusnews Wire | July 2, 2026 - 8.45 am - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 22.06. | DMS GROUP STRENGTHENS ITS GOVERNANCE: APPOINTMENT OF BPIFRANCE INVESTISSEMENT AS A BOARD DIRECTOR | 530 | Actusnews Wire | DMS GROUP STRENGTHENS ITS GOVERNANCE:
APPOINTMENT OF BPIFRANCE INVESTISSEMENT AS A BOARD DIRECTOR
Vladislav TCACI, CFA, Investment Director in the Direct Investment department (Large Cap) of Bpifrance... ► Artikel lesen | |
| 10.06. | DMS GROUP OBTAINS MARKETING AUTHORIZATION FOR ITS NEW ONYX RADIOLOGY MOBILE | 521 | Actusnews Wire | DMS GROUP OBTAINS MARKETING AUTHORIZATION FOR ITS NEW ONYX RADIOLOGY MOBILE
Obtaining certification under the European Medical Device Regulation (MDR)
Commercial launch of ONYX, a new generation... ► Artikel lesen | |
| 01.06. | DMS GROUP RECEIVES EUR 4 MILLION FROM THE EUROPEAN INVESTMENT BANK, 1ST DRAWDOWN OF THE TOTAL FINANCING OF EUR 20 MILLION | 556 | Actusnews Wire | DMS GROUP RECEIVES €4 MILLION FROM THE EUROPEAN INVESTMENT BANK, 1ST DRAWDOWN OF THE TOTAL FINANCING OF €20 MILLION
A long-term European institutional funding to accelerate the development of the... ► Artikel lesen | |
| 21.04. | DMS GROUP: Q1 2026 REVENUE: EUR 10 MILLION | 2.094 | Actusnews Wire | Q1 2026 REVENUE: €10 MILLION
Cyclical slowdown in activity in Q1 2026 - Recovery in growth expected in Q2 2026
Confirmation of the annual outlook: outperforming the medical imaging market... ► Artikel lesen | |
| 14.04. | DMS GROUP: FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR | 856 | Actusnews Wire | FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR
Solid growth in activity of +8.5% in 2025 to €50 million, driven by sustained international development and the North American... ► Artikel lesen | |
| 07.04. | DMS GROUP OBTAINS EUROPEAN MDR CERTIFICATION FOR ITS STRATOS BONE DENSITOMETER RANGE | 632 | Actusnews Wire | April 7, 2026 - 6:00 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 27.03. | DMS GROUP: THE EUROPEAN INVESTMENT BANK GRANTS A FINANCING LINE OF UP TO EUR 20 MILLION | 1.711 | Actusnews Wire | Funding with the support of the European Union, through InvestEU, to accelerate the development of the new generation of medical imaging solutions as part of the next strategic plan Imaging 2030... ► Artikel lesen | |
| 11.03. | Sono-Tek Corporation: Sono-Tek Announces $820K Order for Diagnostic Medical Device Coating Systems | 531 | GlobeNewswire (Europe) | MILTON, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a purchase... ► Artikel lesen | |
| 19.01. | DMS GROUP: EUR 50.0 MILLION IN ANNUAL REVENUE IN 2025, ORGANIC GROWTH OF +9% | 4.659 | Actusnews Wire | Dynamic growth of +17% in activity in Q4 2025, driven by sustained international development
Confirmed acceleration in growth in the 2nd half of 2025 (+14% vs. +3% in the 1st half of 2025)... ► Artikel lesen | |
| 06.01. | DMS GROUP: HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON DECEMBER 31, 2025 | 433 | Actusnews Wire | January 6, 2026 - 5.45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 04.11.25 | DMS GROUP RECEIVES FDA CLEARANCE FOR ITS !M1 MOBILE RADIOLOGY SYSTEM AS PART OF ITS PARTNERSHIP WITH JPI HEALTHCARE SOLUTIONS IN THE UNITED STATES | 1.024 | Actusnews Wire | A new strategic milestone in DMS Group's expansion in North America ahead of RSNA 2025
November 4, 2025 - 5:45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a... ► Artikel lesen | |
| 20.10.25 | DMS GROUP: ACCELERATION OF GROWTH IN THE 3RD QUARTER 2025 | 998 | Actusnews Wire | Quarterly revenue of €11.0 million, up +10%
Dynamism in the Radiology business (+15% in Q3)
Confirmation of the objective of accelerating growth in the 2nd half of 2025 in a less dynamic... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LNA SANTE | 23,400 | 0,00 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,500 | +2,12 % | Fresenius Medical Care: Plötzlicher Führungswechsel schürt Zweifel an Zukunft - Kurs bricht weiter ein | Der überraschende Führungswechsel bei Fresenius Medical Care lässt die Aktie abstürzen und schürt Spekulationen über einen radikalen Kurswechsel im angeschlagenen Dialysegeschäft. Anleger und Analysten... ► Artikel lesen | |
| FRESENIUS | 42,355 | +1,84 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,545 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,140 | +2,30 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,75 | +0,01 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| GENEDX | 67,33 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 32,420 | +4,38 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Sell' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat Carl Zeiss Meditec von "Neutral" auf "Sell" abgestuft und das Kursziel von 27 auf 23 Euro gesenkt. Analyst Richard Felton begründete... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,630 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| HEARTFLOW | 49,730 | -0,02 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| DRAEGERWERK | 116,60 | +4,67 % | Draegerwerk AG & Co. KGaA: Sechsjähriger FDA-Belastungsfaktor beseitigt; US-Monitoring-Geschäft rückt wieder in den Fokus; KAUFEN | Dräger hat ein sechs Jahre währendes regulatorisches Kapitel im US-Patientenmonitoring endlich abgeschlossen. Nach der FDA-Freigabe (Clearance) von Dräger IACS VG8.1 hat die Behörde den 2020 ausgesprochenen... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | -0,12 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,435 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BILLIONTOONE | 98,14 | +0,05 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,940 | +0,04 % | Progyny expects 1.2 million new covered lives in 2027 |
Das Unternehmen DIAGNOSTIC MEDICAL SYSTEMS SA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,826 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIAGNOSTIC MEDICAL SYSTEMS SA finden Sie auf Wallstreet Online.